Reblozyl Injection, Powder, Lyophilized, For Solution
Product Images NDC 59572-775

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Reblozyl (NDC 59572-775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (25 mg Vial Carton)

This appears to be a medication label containing dosage instructions, manufacturer information, and expiration date. The medication is called "WCSSTATIN" and is injected to protect from light. The label also shows the dosage of "25 my/vial" and that it is manufactured by "Celgene Corporation". The lot number is "EXP VL71101.002".*

FDA Label Image

Principal Display Panel (75 mg Vial Carton)

Reblozyl® (luspatercept-aamt) is a medication available as an injection in a single-dose vial. It is used for subcutaneous use only and needs to be reconstituted with sterile water for injection USP before administration. The medication is manufactured by Bristol Myers Squibb Company and registered under US License No. 2252. It is also registered as a trademark of Colgoe Corporation, a subsidiary of Bristol Myers Squibb Company. The dosage information and potency details are not available in the given text.*

FDA Label Image

Reblozyl 03

NOCSTRTIN and Reblozyf are two different injectable drugs containing luspatercept-aamt and are used for subcutaneous administration with a one size dose vial for individuals with certain blood disorders. They are marketed by Bristol Myers Squibb. The exact dosage and administration details can be found on the packaging of the product.*

FDA Label Image

Reblozyl 04

FDA Label Image

Reblozyl 05

Reblozyl (luspatercept-aamt) is an injection drug used for subcutaneous administration after reconstitution with sterile water for injection USP. It comes in a kit containing a single-use vial. Unfortunately, some parts of the text are not readable due to errors.*

FDA Label Image

Reblozyl 06

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.